CO2019013645A2 - Dropropizina en combinación con ambroxol en la forma farmacéutica de jarabe y tabletas - Google Patents
Dropropizina en combinación con ambroxol en la forma farmacéutica de jarabe y tabletasInfo
- Publication number
- CO2019013645A2 CO2019013645A2 CONC2019/0013645A CO2019013645A CO2019013645A2 CO 2019013645 A2 CO2019013645 A2 CO 2019013645A2 CO 2019013645 A CO2019013645 A CO 2019013645A CO 2019013645 A2 CO2019013645 A2 CO 2019013645A2
- Authority
- CO
- Colombia
- Prior art keywords
- dropropizine
- ambroxol
- combination
- syrup
- tablets
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
Abstract
La presente invención se refiere a una combinación farmacéutica de ambroxol o una sal farmacéuticamente aceptable del mismo y dropropizina. Asimismo, se refiere a una composición farmacéutica, preferentemente en una forma de administración oral, que contiene dichos ingredientes activos, junto con uno o más aditivos farmacéuticamente aceptables. La invención también se refiere a los procesos de preparación y los procesos de uso de la combinación farmacéutica o la composición farmacéutica de la presente invención.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2017014725A MX2017014725A (es) | 2017-11-16 | 2017-11-16 | Dropropizina en combinacion con ambroxol en la forma farmaceutica de jarabe y tabletas. |
PCT/IB2018/052699 WO2019097309A1 (es) | 2017-11-16 | 2018-04-19 | Dropropizina en combinación con ambroxol en la forma farmacéutica de jarabe y tabletas |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2019013645A2 true CO2019013645A2 (es) | 2020-01-17 |
Family
ID=66538528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2019/0013645A CO2019013645A2 (es) | 2017-11-16 | 2019-12-03 | Dropropizina en combinación con ambroxol en la forma farmacéutica de jarabe y tabletas |
Country Status (9)
Country | Link |
---|---|
US (2) | US20210128496A1 (es) |
CL (1) | CL2019002446A1 (es) |
CO (1) | CO2019013645A2 (es) |
CR (1) | CR20190401A (es) |
DO (1) | DOP2019000233A (es) |
MX (1) | MX2017014725A (es) |
NI (1) | NI201900084A (es) |
PE (1) | PE20191820A1 (es) |
WO (1) | WO2019097309A1 (es) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1203721B (it) * | 1983-12-29 | 1989-02-23 | Dompe Farmaceutici Spa | Composti otticamente attivi ad attivita' antitosse e sedativa centrale,procedimento per la preparazione e composizioni che li contengono |
DE19933148A1 (de) * | 1999-07-20 | 2001-01-25 | Boehringer Ingelheim Int | Ambroxolhaltige Lutschtablette |
KR101915056B1 (ko) * | 2012-04-10 | 2018-11-07 | 한미약품 주식회사 | 암브록솔, 레보드로프로피진 및 완충제를 포함하는 경구용 액상 제제 및 이의 제조방법 |
-
2017
- 2017-11-16 MX MX2017014725A patent/MX2017014725A/es unknown
-
2018
- 2018-04-19 CR CR20190401A patent/CR20190401A/es unknown
- 2018-04-19 WO PCT/IB2018/052699 patent/WO2019097309A1/es active Application Filing
- 2018-04-19 PE PE2019002014A patent/PE20191820A1/es unknown
- 2018-04-19 US US16/497,269 patent/US20210128496A1/en not_active Abandoned
-
2019
- 2019-07-31 NI NI201900084A patent/NI201900084A/es unknown
- 2019-08-26 CL CL2019002446A patent/CL2019002446A1/es unknown
- 2019-09-12 DO DO2019000233A patent/DOP2019000233A/es unknown
- 2019-12-03 CO CONC2019/0013645A patent/CO2019013645A2/es unknown
-
2023
- 2023-11-17 US US18/512,349 patent/US20240082176A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
MX2017014725A (es) | 2019-05-17 |
US20240082176A1 (en) | 2024-03-14 |
CL2019002446A1 (es) | 2019-12-13 |
CR20190401A (es) | 2019-11-18 |
PE20191820A1 (es) | 2019-12-27 |
WO2019097309A1 (es) | 2019-05-23 |
DOP2019000233A (es) | 2019-12-15 |
US20210128496A1 (en) | 2021-05-06 |
NI201900084A (es) | 2020-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2019000945A2 (es) | Moduladores del receptor nmda espiro-lactam y uso de los mismos | |
CO2019000938A2 (es) | Moduladores nmda espiro-lactam y métodos de uso de los mismos | |
CO2019000943A2 (es) | Moduladores del receptor nmda espiro-lactam y uso de los mismos | |
CO2019000941A2 (es) | Moduladores del receptor nmda espiro-lactam y uso de los mismos | |
CO2019000944A2 (es) | Moduladores del receptor nmda spiro-lactam y bis-spiro-lactam y uso de los mismos | |
GT201700270A (es) | Unidad de dosificación orodispersable que contiene un componente estetrol | |
DOP2016000254A (es) | Formulaciones farmeceuticas de inhibidor de la quinasa pan-raf, procedimientos para su preparacion, y metodos de uso. | |
ECSP16086247A (es) | (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
AR115913A1 (es) | Formas de dosificación oral biodisponibles, uso, métodos | |
CO2019013645A2 (es) | Dropropizina en combinación con ambroxol en la forma farmacéutica de jarabe y tabletas | |
TR201721700A2 (tr) | Saksagli̇pti̇ni̇n ağizda dağilan formülasyonlari | |
CO2018013792A2 (es) | Regímenes de dosificación de vortioxetina para el rápido inicio del efecto antidepresivo | |
EA201590732A1 (ru) | Диспергируемая таблетка | |
AR115724A1 (es) | Composición farmacéutica que contiene un péptido | |
UY37413A (es) | Formulaciones de liberación inmediata de oprozomib | |
CO2019008347A2 (es) | Composición de liberación rápida de cinitaprida y simeticona y proceso para prepararla | |
EA202092800A1 (ru) | Фармацевтическая композиция немедленного высвобождения для противовоспалительных лекарственных средств с фамотидином и карбонатом | |
CR20150411A (es) | Composiciones farmacéuticas que contienen dexketoprofeno y tramadol | |
AR099330A1 (es) | Uso de paricalcitol en el tratamiento de la anemia inflamatoria | |
PE20151431A1 (es) | Formulaciones de lorazepam de liberacion controlada | |
CO2020006701A2 (es) | Composiciones farmacéuticas orales de lorazepam resistentes al alcohol | |
UA113237U (uk) | Фармацевтична комбінація ацеклофенаку і снодійного або заспокійливого компонента | |
EA201800226A1 (ru) | Фармацевтическая композиция, обладающая анксиолитическим и снотворным действием | |
UA97982U (uk) | Лікарський засіб седативної дії у вигляді таблеток | |
MX2017001192A (es) | Composicion farmaceutica de loratadina, fenilefrina, paracetamol y amantadina para su administracion oral, para el tratamiento de alopatias relacionadas a un resfriado comun. |